Correlation Between Ultimovacs ASA and Byggma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ultimovacs ASA and Byggma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultimovacs ASA and Byggma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultimovacs ASA and Byggma, you can compare the effects of market volatilities on Ultimovacs ASA and Byggma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultimovacs ASA with a short position of Byggma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultimovacs ASA and Byggma.

Diversification Opportunities for Ultimovacs ASA and Byggma

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Ultimovacs and Byggma is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Ultimovacs ASA and Byggma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Byggma and Ultimovacs ASA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultimovacs ASA are associated (or correlated) with Byggma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Byggma has no effect on the direction of Ultimovacs ASA i.e., Ultimovacs ASA and Byggma go up and down completely randomly.

Pair Corralation between Ultimovacs ASA and Byggma

Assuming the 90 days trading horizon Ultimovacs ASA is expected to generate 1.58 times more return on investment than Byggma. However, Ultimovacs ASA is 1.58 times more volatile than Byggma. It trades about 0.18 of its potential returns per unit of risk. Byggma is currently generating about 0.02 per unit of risk. If you would invest  205.00  in Ultimovacs ASA on September 25, 2024 and sell it today you would earn a total of  39.00  from holding Ultimovacs ASA or generate 19.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Ultimovacs ASA  vs.  Byggma

 Performance 
       Timeline  
Ultimovacs ASA 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ultimovacs ASA are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating essential indicators, Ultimovacs ASA disclosed solid returns over the last few months and may actually be approaching a breakup point.
Byggma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Byggma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Ultimovacs ASA and Byggma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ultimovacs ASA and Byggma

The main advantage of trading using opposite Ultimovacs ASA and Byggma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultimovacs ASA position performs unexpectedly, Byggma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Byggma will offset losses from the drop in Byggma's long position.
The idea behind Ultimovacs ASA and Byggma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA